Human Pim-2 gene expression in acute myeloid and acute lymphoblastic leukemia patients and complete remission

Advances in Clinical and Experimental Medicine

Volumn 19, Issue 1, 2010, Pages 99-104

  Kapelko Słowik, Katarzyna ^a   Urbaniak Kujda, Donata ^a   Wołowiec, Dariusz ^a   Dybko, Jarosław ^a   Słowik, Mirosław ^b   Potoczek, Stanisław ^a   Kuliczkowski, Kazimierz ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b Department and Clinic of Ophthalmology ^*  (Poland)

Author keywords

Acute lymphoblastic leukemia; Acute myeloid leukemia; hPim 2

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DENSITOMETRY; GENE; GENE EXPRESSION; HUMAN; LEUKEMIA REMISSION; LEUKOCYTE COUNT; PIM 2 GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 77950955440     PISSN: 1230025X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Breuer ML, Cuypers HT, Berns A: Evidence for the involvement of pim-2, a new common proviral insertion site, in progression of lymphomas. EMBO 1989, 8, 743-748.
2. Baytel D, Shalom S, Madgar I, Weissenberg R, Don J: The human Pim-2 proto-oncogene and its testicular expression. Biochim Biophys Acta 1998, 1442, 274-285.
3. Mikkers H, Allen J, Knipscheer P, Romeyn L, Hart A, Vink E, Berns A: High-throughput retroviral tagging to indentify components of specific signaling pathways in cancer. Nat Genet 2002, 32,153-159.
4. Reeves R, Spies GA, Kiefer M, Barr PJ, Power M: Primary structure of putative human oncogene, pim-1. Gene 1990, 90, 303-307.
5. Fox JC, Hammerman PS, Cinalli RM, Master SR, Chodosh LA, Thompson CB: The serine/threonine kinase Pim-2 is transcriptionally regulated apoptotic inhibitor. Gene Dev 2003, 17, 1841-1854.
6. Clemens MJ, Bushell M, Jeffrey I, Pain VM, Morley SJ: Translation initiation factor modification and the regulation of protein synthesis in apoptotic cells. Cell Death Differ 2000, 7, 603-615.
7. Hammerman PS, Fox CJ, Brinbaum MJ, Thompson CB: Pim and Akt oncogenes are independent regulators of haematopoietic cell growth and survival. Blood 2005, 105, 11, 4477-4483.
8. Allen J, Verhoeven E, Domen J, van der Valk M, Berns A: Pim-2 transgene induces lymphoid tumors, exhibiting potent synergy with c-myc. Oncogene 1997, 15, 1133-1141. (Pubitemid 27429616)
9. Zhang Y, Wang Z, Li X, Magnuson NS: Pim kinase dependent inhibition of c-Myc degradation. Oncogene 2008, 27, 4809-4819.
10. Dai H, Li R, Wheeler I, Diaz de Vivar A, Frolov A, Tahir S, Agoulnik I, Thompson T, Rowley D, Ayala G: Pim-2 upregulation: biological implications associated with disease progression and perineural invasion in prostate cancer. Prostate 2005, 65, 3, 276-286. (Pubitemid 41443733)
11. Cohen AM, Grinblat B, Bessler H, Kristt D, Kremer A, Schwartz A, Halperin M, Shalom S, Merkel D, Don J: Increased expression of the hPim-2 gene in human chronic lymphocytic leukaemia and non-Hodgkin lymphoma. Leuk Lymphoma 2004, 45, 5, 951-955. (Pubitemid 38444671)
12. Amson R, Sigaux F, Przedborski S, Flandrin G, Givol D, Telerman A: The human proto-oncogene product p33pim is expressed during fetal haematopoiesis and in diverse leukaemias. Proc Natl Acad Sci USA, 1989, 86, 8857-8861. (Pubitemid 20010324)
13. White E: The pims and outs of survival signaling: role for Pim-2 protein kinase in the suppression of apoptosis by cytokines. Genes Dev 2003, 17, 1813-1815.
14. Yan B, Zemskova M, Holder S, Chin V, Kraft A, Koskinen PJ, Lilly M: The PIM-2 kinase phosphorylates BAD on serine 112 and reverses BAD-induced cell death. J Biol Chem 2003, 14, 278, 46, 45358-45367. (Pubitemid 37432672)
15. Macdonald A, Campbell DG, Toth R, McLauchlan H, Hastie CJ, Arthur JSC: Pim kinases phosphorylate multiple sites on Bad and promote 14-3-3 binding and dissociation from Bcl-XL. BMC Cell Biol 2006, 7, 1-14. (Pubitemid 43256852)
16. Dai JM, Zhang SQ, Zhang W, Lin RX, Ji ZZ, Wang SQ: Antisense oligodeoxynucleotides targeting the serine/threonine kinase Pim-2 inhibited proliferation of DU-145 cells. Acta Pharmacol Sin 2005, 26, 3, 64-68. (Pubitemid 40388075)
17. Gong J, Wang J, Ren K, Liu C, Li B, Shi Y: Serine/threonine kinase Pim-2 promotes liver tumorigenesis induction through mediating survival and preventing apoptosis of liver cell. J Surg Res 2008, 10.1016/j.jss.2008.03.033.
18. Zhang SQ, Du QY, Ying Y, Ji ZZ, Wang SQ: Polymerase synthesis and potential interference of a small-interfering RNA targeting hPIM-2. World J Gastroenterol 2004, 10, 18, 2557-2660. (Pubitemid 39214497)
19. Adam M, Pogacic V, Bendit M, Chappuis R, Nawijn M,Duyster J, Fox CJ, Thompson CB, Cools J, Schwaller J: Targeting PIM kinases impairs survival of haematopoietic cells transformed by kinase inhibitor-sensitive and kinase inhibitor-resistant forms of Fms-like tyrosine kinase 3 and BCR/ABL. Cancer Res 2006, 66, 7, 3828-3835.